Drug-induced systemic lupus erythematosus
- 15 February 1985
- journal article
- review article
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 77 (3) , 231-242
- https://doi.org/10.1080/00325481.1985.11698908
Abstract
No one likes to think that a drug given to cure a disease has instead caused one. Yet, that is exactly what happens in as many as 10% of diagnosed cases of systemic lupus erythematosus (SLE). To date, three drugs have been confirmed as having lupus-producing potential and about 40 more have been implicated. Stressing the reversibility of drug-induced SLE, Dr Kale urges a high index of suspicion for this iatrogenic disease and outlines means of differentiating it from spontaneous SLE.Keywords
This publication has 6 references indexed in Scilit:
- Pharmacogenetic studies on the drug‐related lupus syndrome. differences in antinuclear antibody development and drug‐induced DNA damage in rapid and slow acetylator animal modelsArthritis & Rheumatism, 1981
- The implications of procainamide metabolism to its induction of lupusArthritis & Rheumatism, 1981
- Drug-induced lupus: An adjuvant disease?The American Journal of Medicine, 1981
- Acetylator Phenotype and Lupus ErythematosusClinical Pharmacokinetics, 1981
- Drug-induced systemic lupus erythematosus: A critical reviewSeminars in Arthritis and Rheumatism, 1975
- SENSITIVITY TO SULFADIAZINE RESEMBLING ACUTE DISSEMINATED LUPUS ERYTHEMATOSUSArchives of Dermatology, 1945